Atlas Trials

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Clinical trial NCT04753177 · UNKNOWN

Trial details

NCT number
NCT04753177
Sponsor
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
The Neoadjuvant Therapy
Start date
2021-01-28
Primary completion
2023-01-28
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.